This past year has seen various developments in the field of oncolytic virus therapies - in fundraising and in the clinic.

New narcolepsy treatments are being tested in the clinic, and recently, some of them have made promising strides. How far ...

Learn how Deep Science Ventures’ zero-data approach tackles biotech’s early funding challenges to speed innovation and reduce ...

Meet 12 biotech companies with promising genetic disease therapies that successfully closed funding rounds recently.

Get the 2025 update on the biotech companies Labiotech spotlighted in 2024 — who advanced, who stalled, and who surprised us.

NATO Innovation Fund backs Portal Biotech in its first biotech move. What does this signal for strategic investment in ...

With one of the most densely concentrated life sciences hubs in Europe, the Netherlands sets its sights on becoming a global biotech leader.

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article.

We unpack the full scope of the U.S. budget cuts, from canceled clinical trials and stalled drug approvals to mass layoffs and lawsuits.

As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval in 2025.

From AI to gene therapy, we reached out to industry experts to get their thoughts on the trends that will shape the biotech industry in 2025.